http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3929802-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f9afcd0369d6402247555a4656c0917 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-91 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-91 |
filingDate | 1974-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1975-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51d2100cd55f2a5f035e326d8c1b3f74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9df65eb5c0dec3473365306221ac601b |
publicationDate | 1975-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-3929802-A |
titleOfInvention | Bis-basic ethers of dibenzofuran |
abstract | The novel bis-basic ethers of dibenzofuran of the present invention have useful antiviral properties. These new compounds are represented by the formula WHEREIN EACH X is A. the group WHEREIN N IS A WHOLE INTEGER OF FROM 0 TO 2, M IS 1 OR 2, AND R2 is hydrogen, lower alkyl having from 1 to 6 carbon atoms, or alkenyl of from 3 to 6 carbon atoms and having the vinyl unsaturation in other than the 1-position of the alkenyl group. This invention also includes pharmaceutically acceptable acid addition salts of the base compounds represented by Formula I. These new compounds may be prepared by several different methods which are described. wherein each A is a straight or branched alkylene chain having from 2 to 6 carbon atoms and which separates the amino nitrogen and oxygen by at least 2 carbon atoms; R and R1 are individually hydrogen, lower alkyl having from 1 to 6 carbon atoms, cycloalkyl having from 3 to 6 carbon atoms, alkenyl having from 3 to 6 carbon atoms and having the vinyl unsaturation in other than the 1-position of the alkenyl group; or each set of R and R1 taken together with the nitrogen atom to which they are attached is a saturated monocyclic heterocyclic group such as pyrrolidino, piperidino, morpholino, or N-(lower)alkylpiperazino; or B. the group |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0151479-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0352530-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0352530-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005075332-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0057362-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6800656-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0151479-A3 |
priorityDate | 1970-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 145.